Ignite Creation Date:
2025-12-24 @ 7:55 PM
Ignite Modification Date:
2025-12-30 @ 8:21 PM
Study NCT ID:
NCT01441804
Status:
UNKNOWN
Last Update Posted:
2013-10-01
First Post:
2011-09-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Randomized Trial of 24-Week Versus 48-Week Courses of Peginterferon Plus Ribavirin for Patients With Genotype 1 Hepatitis C and IL28B CC Polymorphism
Sponsor:
Third Affiliated Hospital, Sun Yat-Sen University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-05
Start Date Type:
None
Primary Completion Date:
2014-05
Primary Completion Date Type:
ESTIMATED
Completion Date:
2014-08
Completion Date Type:
ESTIMATED
First Submit Date:
2011-09-24
First Submit QC Date:
None
Study First Post Date:
2011-09-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-09-28
Last Update Post Date:
2013-10-01
Last Update Post Date Type:
ESTIMATED